Skip to content
FLFunding Landscape
Open·Ingested 90 days ago, not re-verified since

DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)
Posted
May 4, 2026
Amount
$5,600,000
Closes
Sep 30, 2026 (in 58 days)

Get alerted when new grant funding like this opens.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526ALSRPPCTA
Assistance listing (CFDA)
12.420

Amount

$5,600,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Pilot Clinical Trial Award (PCTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of amyotrophic lateral sclerosis (ALS). Projects may range from phase 1 to small-scale phase 2 trials. Applications must address one of the following focus areas: · Biomarker-Driven Interventions: Disease-modifying interventions, with mechanism-specific biomarkers to predict which clinical trial participants are likely to respond, demonstrate target engagement, and effects on the intended biological pathway. · Clinical Care: Improving aspects of clinical care and symptom management for ALS. Distinctive Features: Funding from this award ...

Related opportunities

Refine this search